Narkewicz M R, Thureen P J, Sauls S D, Tjoa S, Nikolayevsky N, Fennessey P V
Department of Pediatrics, University of Colorado Health Sciences Center, Denver 80262, USA.
Pediatr Res. 1996 Jun;39(6):1085-90. doi: 10.1203/00006450-199606000-00025.
Using stable isotopes of serine, glycine, and glutamine, the metabolism of serine and glycine was investigated in primary hepatocytes from six mid-gestation fetal lambs (mean gestational age = 81 +/- 6 d, normal gestation = 145 d). Serine production was 6.84 +/- 1.22 mumol/24 h/mg of DNA and exceeded serine utilization (3.76 +/- 1.44 mumol/24 h/mg of DNA) with a resultant net increase in medium serine of 2.58 +/- 1.70 mumol/24 h/mg of DNA. In contrast, glycine production (6.84 +/- 1.16 mumol/24 h/mg of DNA) was less than glycine utilization (12.10 +/- 1.78 mumol/24 h/mg of DNA) with a net decline in medium glycine of -5.44 +/- 2.03 mumol/24 h/mg of DNA. Of the serine produced, 50.4 +/- 4.3% was derived from glycine via the action of serine hydroxymethyltransferase (SHMT) and the glycine cleavage enzyme complex (GCS). Increasing the medium serine concentration resulted in an increase in serine utilization and sparing of the utilization of other amino acids. Biosynthesis of glycine from serine accounts for only 18.1 +/- 5.6% of glycine production, and this percentage is not affected by changes in medium serine concentration. Using 2.5-[15N2]glutamine as the tracer, an estimated 18 +/- 7% of serine production was derived from transamination reactions. The specific activity of both cytosolic and mitochondrial SHMT was constant for the duration of the cultures. We conclude that, in mid-gestation fetal ovine hepatocytes, there is net production of serine (with glycine as the primary metabolic source of this serine biosynthesis) and net glycine utilization. These data suggest that flux through SHMT and GCS accounts for 50% of serine biosynthesis in mid-gestation fetal ovine hepatocytes. The sparing of the utilization of other amino acids by serine suggests that serine a conditionally essential amino acid for the mid-gestation fetal liver.
利用丝氨酸、甘氨酸和谷氨酰胺的稳定同位素,对6只妊娠中期胎羊(平均胎龄=81±6天,正常妊娠期=145天)原代肝细胞中丝氨酸和甘氨酸的代谢进行了研究。丝氨酸生成量为6.84±1.22μmol/24小时/毫克DNA,超过丝氨酸利用率(3.76±1.44μmol/24小时/毫克DNA),导致培养基中丝氨酸净增加2.58±1.70μmol/24小时/毫克DNA。相比之下,甘氨酸生成量(6.84±1.16μmol/24小时/毫克DNA)低于甘氨酸利用率(12.10±1.78μmol/24小时/毫克DNA),培养基中甘氨酸净减少-5.44±2.03μmol/24小时/毫克DNA。在生成的丝氨酸中,50.4±4.3%通过丝氨酸羟甲基转移酶(SHMT)和甘氨酸裂解酶复合物(GCS)的作用来自甘氨酸。增加培养基中丝氨酸浓度会导致丝氨酸利用率增加,并节省其他氨基酸的利用。由丝氨酸生物合成甘氨酸仅占甘氨酸生成量的18.1±5.6%,且该百分比不受培养基中丝氨酸浓度变化的影响。使用2.5-[15N2]谷氨酰胺作为示踪剂,估计18±7%的丝氨酸生成来自转氨反应。在培养期间,胞质和线粒体SHMT的比活性均保持恒定。我们得出结论,在妊娠中期胎羊肝细胞中,存在丝氨酸的净生成(甘氨酸是该丝氨酸生物合成的主要代谢来源)和甘氨酸的净利用。这些数据表明,通过SHMT和GCS的通量占妊娠中期胎羊肝细胞中丝氨酸生物合成的50%。丝氨酸对其他氨基酸利用的节省表明,丝氨酸是妊娠中期胎儿肝脏的一种条件必需氨基酸。